Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: J Clin Gastroenterol. 2023 Jan 1;57(1):103–110. doi: 10.1097/MCG.0000000000001710

Table 5.

Comparisons between current and ENDPAC models.

Current Model ENDPAC Model
Predictors Age, weight change, HbA1c change, HbA1c change rates (or HbA1c in prior 6 or 18 months) Age, weight change, glycemic change
Number of predictors 4 3 with information from 4 dimensions*
Population • Single elevated HbA1c
• No long-standing diabetes
• No history of pancreatic cancer
• 12 months continuous health plan enrollment
New onset of diabetes:
• Two consecutive elevated glycemic tests within 90 days or one elevated glycemic lab followed by diabetes treatment
• No history of diabetes treatment
• No history of pancreatic cancer
• Normal glycemic test* in prior 18 months
• 12 months continuous health plan enrollment
Implementation in the current study for the purpose of comparison with the PAC-Glycemia Model:
• Two consecutives elevated HgA1c within 90 days
• No history of pancreatic cancer
• Normal HgA1c in prior 18 months
• 12 months continuous health plan enrollment
Time period 1/1/2010 and 09/30/2018 1/1/2010 and 09/30/2018
Number of eligible patients 109k 18k
Number of PDAC events 319 95
Incidence rate 1.4/1,000 person-years of follow-up 2.0/1,000 person-years of follow-up
*

See more details in DISCUSSION Section.